Safety of invasive procedures in end-sta
โ
James D. Perkins
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 84 KB
๐ 1 views
Patients with end-stage liver disease (ESLD) are predisposed to bleeding complications due to thrombocytopenia, reduced synthesis of coagulation factors, and increased fibrinolytic activity. The exact incidence of vascular access site and bleeding complications related to cardiac catheterization in